[P002] Poster

1:00 PM - 1:50 PM JST(4:00 AM - 4:50 AM UTC)

[P01-152] Unlocking the Industrial Potential of Microbial Intelligence Through Data-Driven Fermentation Optimization

Gwenael Servant¹, ○Miru Tanaka¹ (1. Abolis Biotechnologies (France))

Keywords:

Fermentation optimization,Omics data,Microbiome,Bioprocessing,Metabolic pathways

The industrial exploitation of microbial systems has long been constrained by a fundamental gap between biological complexity and operational insight. While genomics, transcriptomics, and metabolomics have generated unprecedented volumes of data about microbial behavior, translating these datasets into actionable process improvements has remained an elusive challenge for scientists and engineers alike. Microbiome Studio (MSio) represents a paradigm shift in how the microbiome can be understood, harnessed, and optimized for industrial and biotechnological applications.At its core, MSio is a software platform designed to bridge the critical divide between omics data acquisition and real-world fermentation performance. The platform enables users to comprehensively characterize what microbes are capable of doing in a given process, what they are actually doing under defined conditions, and — crucially — how they can be guided to perform better. This three-dimensional understanding of microbial behavior forms the foundation of a new generation of data-driven bioprocessing, applicable across the food, biotics, and biotechnology sectors.The value proposition of MSio spans multiple dimensions. In fermentation optimization, the platform functions are numerous: integrating real-time biological intelligence with process parameter management to maximize yield, productivity, and quality while minimizing metabolic bottlenecks and inhibitory by-products. Key capabilities include prototrophy and auxotrophy mapping from genomic data, strain-to-strain comparative analysis, media optimization through metabolic pathway interrogation, and the design of synbiotics and microbial consortia with complementary metabolic profiles. The platform's unique data quality control system further distinguishes it from competing tools by providing transparent confidence scoring, enabling users to accurately interpret results and make informed decisions.The addressable market for such solution is substantial with the full spectrum of the fermentation and microbiome industry — from global multinationals, to innovative small and mid-sized companies working in probiotics, precision fermentation, cosmetics, and agricultural biotechnology. MSio is positionned not merely as a software product, but as the central intelligence layer of a new microbial-led industrial revolution — where biology, data, and engineering converge to deliver transformative value.